Health TrialsbyHealthPanel

Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital

ConditionCentral Line-associated Bloodstream Infection (CLABSI)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1+
SponsorPort Said University

About this trial

* Review key history and clinical examination findings of cases with CLABSI. * Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI. * Determine antibiotic biogram of each organism isolated * Determine the prevalence of occurrence of Primary or secondary Blood stream infection, causing microorganism, and predisposing factors.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Patients diagnosed with sepsis based on medical history, lab investigations and clinical picture.

Both sex, and all age-groups.

Disqualifiers

Patients diagnosed with sepsis proved by medical history, lab investigations and clinical picture who received non-beta lactam antibiotics for the past 24 hours.

Samples proved contaminated by microbial flora will be rejected.

Trial population

Venous blood samples from cases with suspected sepsis, or bacteremia will be incubated with a medium which encourages promotes bacterial growth.

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

  • Blood Catheters

    Device

    Central line as a predisposing factor for Blood stream infection

Treatment groups

600 Participants
are divided into 4 treatment groups
Group A: No of Positive CLABSI1 intervention
Group B: Primary Blood stream infection1 intervention
Group C: Secondary Blood stream infection1 intervention
Group D: Blood Prevalence of types microorg.0 interventions

Trial outcomes

Primary outcomes

1

• Microbiological diagnosis and Culture sensitivity tests

• Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI.

Time frame
6 months
2

Determine antibiotic biogram of each organism isolated

Determine antibiotic biogram of each organism isolated

Time frame
6 months

Secondary outcomes

1

•Determine the prevalence of occurrence of Primary or secondary Blood stream infection

•Determine the prevalence of occurrence of Primary or secondary Blood stream infection, causing microorganism, and predisposing factors.

Time frame
4 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Port Said University

Lead sponsor

Source ClinicalTrials.gov
Apply now